SPARK NS is now accepting applications from academic researchers developing therapeutics for autism, Parkinson's disease, and adjacent disorders for the 2027 Cohort of the SPARK NS Translational Research Program. Selected projects will receive milestone-based funding of up to $2,000,000 over two years, along with extensive support across all aspects of translational research and drug development. Deadline for applications 05 Jun, 2026 Further information and application
